Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
PULMATRIX, INC. logo

PULMATRIX, INC.

Recent Finacing

Series B I

Recent Raise

$14M

Pulmatrix is a Lexington, MA clinical-stage biotech developing inhaled, host-targeted respiratory therapies via iCALM and iSPERSE platforms, advancing PUR118 and other formulations through clinical trials for COPD and CF.

Founded 2003
Massachusetts, United States
11-50
Publicly Traded
pulmatrix.com

Highlights

Focus Areas

Biotechnology
Pharmaceutical
Therapeutics

Recent Investors

Novartis logo
ARCH Venture Partners logo
Polaris Partners logo
5AM Ventures logo
National Institute of Allergy and Infectious Diseases logo

Financials

$46.4M

Total Raised

2

Funding rounds

5

Investors